title: Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A.
abstract: The activity of the factor VIII coagulation protein can be measured by three methods: a one or two-stage clotting assay and a chromogenic assay. The factor VIII activity of most individuals with mild hemophilia A is the same regardless of which method is employed. However, approximately 30% of patients show marked discrepancies in factor VIII activity measured with the different methods. The objective of this study was to investigate the incidence of assay discrepancy in our center, assess the impact of alternative reagents on factor VIII activity assays and determine the usefulness of global assays of hemostasis in mild hemophilia A. Factor VIII activity was measured in 84 individuals with mild hemophilia A using different reagents. Assay discrepancy was defined as a two-fold or greater difference between the results of the one-stage and two-stage clotting assays. Rotational thromboelastometry and calibrated automated thrombography were performed. Assay discrepancy was observed in 31% of individuals; 12% with lower activity in the two-stage assay and 19% with lower activity in the one-stage assay. The phenotype could not always be predicted from the individual's genotype. Chromogenic assays were shown to be a suitable alternative to the two-stage clotting assay. Thromboelastometry was found to have poor sensitivity in hemophilia. Calibrated automated thrombography supported the results obtained by the two-stage and chromogenic assays. The current international guidelines do not define the type of assay to be used in the diagnosis of mild hemophilia A and some patients could be misclassified as normal. In our study, 4% of patients would not have been diagnosed on the basis of the one-stage factor VIII assay. Laboratories should use both one stage and chromogenic (or two-stage) assays in the diagnosis of patients with possible hemophilia A.
authors.affiliation: m.makris@sheffield.ac.uk.
authors.forename: Annette E
authors.initials: AE
authors.lastname: Bowyer
authors.forename: Joost J
authors.initials: JJ
authors.lastname: Van Veen
authors.forename: Anne C
authors.initials: AC
authors.lastname: Goodeve
authors.forename: Steve
authors.initials: S
authors.lastname: Kitchen
authors.forename: Michael
authors.initials: M
authors.lastname: Makris
mesh_terms: D001777:Blood Coagulation / Q000502:physiology; D001780:Blood Coagulation Tests / Q000379:methods / Q000592:standards*; D005260:Female; D006467:Hemophilia A / Q000097:blood* / Q000175:diagnosis*; D006801:Humans; D008297:Male; D013916:Thrombelastography / Q000379:methods / Q000592:standards